Hikma Pharmaceuticals, an Amman, Jordan-based pharmaceutical company, has agreed to acquire Medlac Pharma Italy Co. (Medlac), an injectable manufacturing company in Hoa Lac Hi-Tech Park, Vietnam. The acquisition includes an injectable facility, adjacent vacant land, Medlac’s product portfolio of 23 injectable products, its pipeline, and all employees.

Medlac operates an injectables facility in Hanoi, Vietnam. The company began operations in 2012 and is focused on manufacturing anti-infective and cardiovascular drugs.

Hikma is a manufacturer of generic injectables in the US and has a growing presence in Europe and the Middle East and North Africa.

Source: Hikma Pharmaceuticals